Stock listing

NASDAQ:PCSA Processa Pharmaceuticals, Inc. Stock

Home listing (NASDAQ) of Processa Pharmaceuticals, Inc.

Follow Processa Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:PCSA

$1.56 USD -0.14 (-8.2%)

Close on Nov 20, 2026

Past year -77.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.39 – $1.66 USDNov 20, 2026
Volume
69,954 sharesNov 20, 2026
Market cap
$4.37M USDAt the close on Nov 20, 2026 · price × 2.80M shares outstanding
52-week range
$1.04 – $8.88 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$131,941 USDMedian day 20,643 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Processa Pharmaceuticals, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:PCSA · Home$1.56 USD-0.14 (-8.2%)69,954$1.64$1.66$1.39$1.70Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PCSA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.56-0.14-8.2%$1.64$1.66$1.3969,954
$1.70-0.03-1.7%$1.701$1.76$1.6929,390
$1.73+0.01+0.6%$1.75$1.76$1.7020,643
$1.72-0.14-7.5%$1.80$1.838$1.6434,685
$1.86+0.02+1.1%$1.865$1.905$1.8018,724
$1.84-0.03-1.6%$1.81$1.91$1.8016,250
$1.870.000.0%$1.865$1.90$1.7844,999
$1.87-0.08-4.1%$1.90$1.95$1.8617,370
$1.95+0.02+1.0%$1.81$1.95$1.7730,904
$1.93+0.09+4.9%$1.94$1.95$1.868,430
$1.84-0.095-4.9%$1.87$1.91$1.7825,675
$1.935-0.005-0.3%$1.86$1.95$1.8321,555
$1.94+0.09+4.9%$1.78$1.94$1.7814,427
$1.85-0.04-2.1%$1.86$1.89$1.7836,610
$1.890.000.0%$1.81$1.939$1.8125,323
$1.89+0.04+2.2%$1.84$2.10$1.80104,807
$1.85+0.03+1.6%$1.80$1.911$1.75524,072
$1.82+0.025+1.4%$1.76$1.87$1.70613,367
$1.795-0.015-0.8%$1.78$1.85$1.72119,526
$1.81-0.05-2.7%$1.761$1.90$1.75135,000
$1.86+0.10+5.7%$1.71$1.889$1.7116,100
$1.76-0.03-1.7%$1.79$1.79$1.6811,700
$1.79+0.06+3.5%$1.73$1.79$1.5918,200
$1.73+0.04+2.4%$1.74$1.74$1.6919,700
$1.69+0.01+0.6%$1.69$1.75$1.6122,100
$1.68+0.065+4.0%$1.58$1.72$1.5331,100
$1.615-0.155-8.8%$1.75$1.75$1.5646,300
$1.77-0.13-6.8%$1.93$1.93$1.7769,200
$1.90+0.38+25.0%$1.56$1.98$1.50438,300
$1.52+0.17+12.6%$1.32$1.87$1.0412,969,000
$1.35-0.07-4.9%$1.42$1.43$1.3212,800
$1.42-0.10-6.6%$1.53$1.53$1.4112,900
$1.52+0.03+2.0%$1.51$1.59$1.4517,900
$1.49-0.12-7.5%$1.56$1.63$1.4925,700
$1.61-0.01-0.6%$1.73$1.74$1.6014,900
$1.62-0.02-1.2%$1.59$1.645$1.5710,200
$1.64-0.12-6.8%$1.83$1.848$1.5784,100
$1.76-0.08-4.3%$1.76$1.83$1.759,300
$1.840.000.0%$1.84$1.84$1.779,400
$1.84-0.01-0.5%$1.88$1.93$1.808,500
$1.85-0.04-2.1%$1.89$1.939$1.805,100
$1.89+0.01+0.5%$1.90$1.97$1.8654,700
$1.88+0.04+2.2%$1.91$2.02$1.8574,500
$1.84-0.12-6.1%$1.87$1.944$1.8416,500
$1.96+0.06+3.2%$1.92$1.96$1.846,400
$1.90+0.05+2.7%$1.85$1.99$1.8521,800
$1.85-0.107-5.5%$1.93$1.95$1.8517,100
$1.957+0.077+4.1%$1.95$1.96$1.8815,600
$1.88-0.20-9.6%$1.97$2.11$1.8726,800
$2.08+0.23+12.4%$1.90$2.12$1.9039,300
$1.85-0.14-7.0%$1.99$2.03$1.82101,400
$1.99-0.17-7.9%$2.08$2.11$1.9825,500
$2.16+0.10+4.9%$2.15$2.165$2.0535,800
$2.06+0.01+0.5%$2.02$2.083$2.0112,300
$2.05-0.05-2.4%$2.09$2.10$2.0510,300
$2.10+0.05+2.4%$2.05$2.18$2.0512,400
$2.050.000.0%$2.04$2.125$2.0214,400
$2.05-0.01-0.5%$2.08$2.11$2.0215,700
$2.06-0.05-2.4%$2.08$2.14$2.029,600
$2.11-0.02-0.9%$2.07$2.20$2.0715,900
$2.13-0.05-2.3%$2.18$2.22$2.1221,600
$2.18+0.01+0.5%$2.17$2.28$2.1554,500
$2.17+0.09+4.3%$2.11$2.18$2.0430,200
$2.08-0.065-3.0%$2.21$2.22$2.0075,900
$2.145-0.005-0.2%$2.14$2.20$2.1127,500

Splits

4 splits since 2017 · NASDAQ:PCSA · every price before a split is adjusted for it

DayRatioWhat
1-for-25Consolidation
1-for-20Consolidation
1-for-7Consolidation
1-for-7Consolidation
Ticker
NASDAQ:PCSA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Processa Pharmaceuticals (NASDAQ:PCSA) Q4 2022 Earnings Call

    Thu, Mar 30, 2023 · 4:30 PM ET

    Watch Transcript
  • Processa Pharmaceuticals (NASDAQ:PCSA) Q3 2022 Earnings Call

    Tue, Nov 08, 2022 · 4:30 PM ET

    Watch Transcript
  • Processa Pharmaceuticals (NASDAQ:PCSA) Q2 2022 Earnings Call

    Thu, Aug 11, 2022 · 4:30 PM ET

    Watch Transcript

Latest news

All Processa Pharmaceuticals, Inc. news

Financings

  • Private placement of series A non-voting convertible preferred stock

    Jul 29, 2026

    Announced: about US$200M · US$1,221 a share · Leerink Partners +3

    Dealers: Leerink Partners (lead), Evercore ISI, UBS Investment Bank, Wells Fargo Securities

    Buyers: Bain Capital Life Sciences; Janus Henderson Investors; RA Capital Management; SilverArc Capital; ADAR1 Capital Management; Cormorant Asset Management; Integral Health Asset Management; Marshall Wace; Octagon Capital; Soleus Capital

    Use of proceeds: Advance VT-7208 through Phase 2 proof-of-concept studies in food allergy, CSU and RMS; fund operations into second half of 2029

    Announced Jul 29, 2026

  • Strategic investment

    Aug 7, 2025

    Announced: strategic investment

    Announced Aug 7, 2025

  • Public offering of shares of common stock (or pre-funded warrants) with common warrants

    Jun 17, 2025

    Announced: US$7M · US$0.25 a share · Warrants at US$0.25 for 60 months · H.C. Wainwright & Co.

    Dealers: H.C. Wainwright & Co. (lead)

    Use of proceeds: Continue the Phase 2 clinical trial for NCG-Cap, and working capital and general corporate purposes

    Announced Jun 17, 2025

  • Public offering of shares of common stock (or pre-funded warrants) with Series A and Series B warrants

    Jan 30, 2025

    Closed: US$5M raised · US$0.615 a share · Warrants at US$0.65 for 60 months · A.G.P./Alliance Global Partners

    Dealers: A.G.P./Alliance Global Partners (lead)

    Insiders: The Chief Executive Officer and certain board members participated, at $0.7975 per share and accompanying warrants

    Announced Jan 27, 2025 · Closed Jan 30, 2025

Read by 6ix AI from the company's releases

Decks

Processa Pharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
8 in the last 12 months · 89 in all · newest Nov 5, 2026 · oldest 2019
Calls
6 calls with a replay · 6 with a transcript · latest Mar 30, 2023
Decks
42 decks · latest November 2026

Where Processa Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:PCSA · Home listing · This pageNASDAQUnited StatesUSD
BOATS:PCSABOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Processa Pharmaceuticals, Inc.